InAADR

Protein Information

Protein Name: Neuropeptide Y (P01303)
Gene Name: NPY
Description: Neuropeptide Y precursor [Contains: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)]
PDB ID: 1QFA
Protein Family:
Protein Category:

This panel provides drug-protein interaction and their ADRs along with references

Interacting Drugs Toxicity Mechanism Reference
8-OH-DPAT Hyperphagic Syndrome ENHANCED expression of preproNPY mRNA in the arcuate nucleus in obese Zucker rats during repeated administration of mifepristone suggesting an involvement of NPY in the pathophysiology of the hyperphagic syndrome. [ ADR Type 2 ] Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats
8-OH-DPAT Obesity ENHANCED expression of preproNPY mRNA in the arcuate nucleus in obese Zucker rats during repeated administration of mifepristone suggesting genetically determined obesity in Zucker rats [ ADR Type 2 ] Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats
Mifepristone Hyperphagia ENHANCED expression of preproNPY mRNA in the arcuate nucleus in obese Zucker rats during repeated administration of mifepristone suggesting an involvement of NPY in the pathophysiology of the hyperphagic syndrome [ ADR Type 2 ] Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats
Mifepristone Obesity ENHANCED expression of preproNPY mRNA in the arcuate nucleus in obese Zucker rats during repeated administration of mifepristone suggesting genetically determined obesity in Zucker rats [ ADR Type 2 ] Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats
Reserpine Gastric Fundal Mucosa a markedly enhanced output of NPY-LI then occurred upon nerve stimulation,which leads to the rat gastric fundal mucosa and reserpine ulcer [ ADR Type 1 ] Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen
Topiramate Mood-Stabilizing Effects Topiramate normalizes hippocampal NPY-LI in flinders sensitive line #depressed# rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus,which plays a role for mood-stabilizing and weight loss-inducing effects. [ ADR Type 2 3 ] A Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-induce
Topiramate Weight Loss-Inducing Effects Topiramate normalizes hippocampal NPY-LI in flinders sensitive line #depressed# rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus,which plays a role for mood-stabilizing and weight loss-inducing effects. [ ADR Type 2 3 ] A Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-induce

This panel provides information on drug category

Toxicity Source

InAADR: Drug-Protein-ADRs database